These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 621280)

  • 1. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.
    Glauser MP; Lyons JM; Braude AI
    J Clin Invest; 1978 Feb; 61(2):403-7. PubMed ID: 621280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy.
    Slotki IN; Asscher AW
    Nephron; 1982; 30(3):262-8. PubMed ID: 7099339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis.
    Imamoğlu M; Cay A; Cobanoglu U; Bahat E; Karahan C; Tosun I; Sarihan H
    Urology; 2006 Jun; 67(6):1315-9. PubMed ID: 16697444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats.
    Huang A; Palmer LS; Hom D; Anderson AE; Kushner L; Franco I
    J Urol; 1999 Oct; 162(4):1396-8. PubMed ID: 10492222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe renal failure in acute bacterial pyelonephritis: do not forget corticosteroids.
    Sqalli TH; Hamzaoui H; Guiard E; Noel LH; Fakhouri F
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):118-22. PubMed ID: 20061705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in the management of acute suppurative nephritis].
    Kottász S; Szijjártó F
    Orv Hetil; 1982 May; 123(22):1351-3. PubMed ID: 7110689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in pyelonephritis].
    Schmicker R; Handschuck I; Klinkmann H
    Z Gesamte Inn Med; 1976 Jun; 31(22):414-21. PubMed ID: 969772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.
    Giamarellos-Bourboulis EJ; Tziortzioti V; Koutoukas P; Baziaka F; Raftogiannis M; Antonopoulou A; Adamis T; Sabracos L; Giamarellou H
    J Antimicrob Chemother; 2006 May; 57(5):937-44. PubMed ID: 16549515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term study of humoral immune response in patients with chronic pyelonephritis.
    Nimmich W; Budde E; Naumann G; Klinkmann H
    Clin Nephrol; 1976 Oct; 6(4):428-32. PubMed ID: 788977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapy of pyelonephritis].
    Klippel KF
    Fortschr Med; 1974 Aug; 92(22):945-8. PubMed ID: 4409178
    [No Abstract]   [Full Text] [Related]  

  • 11. [The usefulness and hazards of antibiotics in acute suppurative nephritis].
    Szendröi Z
    Orv Hetil; 1971 Nov; 112(48):2880-1. PubMed ID: 5136321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pressing problems in the therapy of chronic pyelonephritis].
    Pytel' IuA; Zolotarev II
    Sov Med; 1978 Oct; (10):3-9. PubMed ID: 715532
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial agents in the management of urinary tract infection: an experimental evaluation.
    Lecamwasam JP; Miller TE
    J Lab Clin Med; 1989 Nov; 114(5):510-9. PubMed ID: 2681480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental therapeutic study on hormonally facilitated pyelonephritis in an acute and chronic test].
    Koch HG; Freiesleben H; Henkel W; Commichau R
    Verh Dtsch Ges Inn Med; 1971; 77():1336-9. PubMed ID: 4949696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic studies on two different models of experimental pyelonephritis (author's transl)].
    Schulz E; Sack K; Freiesleben H; Henkel W
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(2):206-15. PubMed ID: 367005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental pyelonephritis in mice following ascending infection with E. coli. Chronic phase.
    Tanaka N; Une T; Ogawa H
    Acta Pathol Jpn; 1981 Mar; 31(2):189-98. PubMed ID: 7020332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial therapy and the prevention of acute pyelonephritis and its complications].
    Ezdokian AS; Ukhin AV
    Urol Nefrol (Mosk); 1989; (1):70-4. PubMed ID: 2655255
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
    Giamarellos-Bourboulis E; Adamis T; Sabracos L; Raftogiannis M; Baziaka F; Tsaganos T; Koutoukas P; Plachouras D; Karayannacos P; Giamarellou H
    Scand J Infect Dis; 2005; 37(1):48-54. PubMed ID: 15764190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial spectrum and pathogen resistance in chronic primary and secondary pyelonephritis].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Aug; 75(8):579-85. PubMed ID: 6758412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.